Cipla to acquire Brazil's Duomed ProdutosIllustrative image – not actual.

Cipla made an announcement on 9 April that its UK subsidiary, Cipla (EU) would acquire Brazilian firm, Duomed Produtos Farmaceuticos.


It has entered into a definitive agreement for acquisition of 100 per cent stake in Duomed Produtos Farmaceuticos for about Rs 2.6 crore.


The Brazilian health authority (ANVISA) and other regulatory authorities have approved the deal to import and distribute pharmaceutical products in Brazil. By the end of May 2015, the transaction is expected to be completed, subject to certain conditions.


The acquisition is part of Cipla's front-end strategy and will expedite its product registrations in Brazil. Duomed Produtos, a limited liability company in Brazil, was incorporated on 10 June, 2013.


 

← All latest storiesBack to top →